Abivax SA ADR ABVX
$97.61
▼ -4.28% 24H
About
Abivax S.A. American Depositary Receipt represents shares in Abivax SA, a clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms, particularly through enhanced expression of microRNA-124, to stabilize the immune response in patients with chronic inf…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryFrance
Employees80
TickerABVX
Statistics
Market Cap$7.74B
Revenue (TTM)$4.9M
Net Income—
Net Margin—
EPS—
P/E-19.99
P/S1565.41
P/B15.31
EV/EBITDA-29.69
ROE-157.1%
Dividend Yield—
Price$97.61
Data: Twelve Data · Revenue = mcap / P/S